Internal Medicine, Hematology & Oncology · San Juan, PR
NPI
1851656441
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
University Distristrict Hospital, Puerto Rico Medical Center Bo. Monacillos
San Juan, PR, 00935
Phone (787) 754-0101
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
206 services
Medicare patients, 2024
64
Average age 77
Drug cost, 2024
$4.3M
1,767 prescriptions
Company payments, 2025
$4,710
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose E Abreu Arbelo was code 99214 (office e&m - established), 168 times for 49 patients. In total Jose E Abreu Arbelo billed 206 services in 8 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 168 | 49 | $68.11 | $11K |
| 38222 Other Organ Systems | Facility | 13 | 13 | $55.26 | $718 |
By year: 2022 $18K for 306 services; 2023 $18K for 261 services; 2024 $14K for 206 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose E Abreu Arbelo prescribed most often to Medicare patients was Anastrozole, with 251 prescriptions and refills. In total Jose E Abreu Arbelo wrote 1,767 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 251 | 371 | 51 | $4,856 |
| Famotidine Generic | 57 | 63 | 26 | $298 |
| Gabapentin Generic | 56 | 58 | 19 | $436 |
| Letrozole Generic | 49 | 77 | 11 | $891 |
| Tagrisso Osimertinib Mesylate | 47 | 47 | Under 11 | $784K |
| Ondansetron Odt Ondansetron | 43 | 43 | 26 | $814 |
| Exemestane Generic | 39 | 71 | Under 11 | $6,697 |
| Revlimid Lenalidomide | 37 | 37 | Under 11 | $597K |
| Tamoxifen Citrate Generic | 33 | 53 | Under 11 | $1,247 |
| Ibrance Palbociclib | 33 | 33 | Under 11 | $524K |
| Pantoprazole Sodium Generic | 33 | 43 | 15 | $320 |
| Montelukast Sodium Generic | 30 | 32 | 13 | $285 |
| Prednisone Generic | 29 | 29 | Under 11 | $217 |
| Dexamethasone Generic | 29 | 29 | 15 | $532 |
| Alendronate Sodium Generic | 28 | 37 | Under 11 | $307 |
Brand drugs: - claims; generic drugs: 1,373 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose E Abreu Arbelo $4,710 ($4,710 in general payments such as food, travel and fees) from 37 companies. The largest payer was Janssen Pharmaceuticals, Inc with $412.
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc JNJ | 20 | $412 |
| AstraZeneca Pharmaceuticals LP AZN | 17 | $379 |
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $358 |
| Pbg Puerto Rico LLC | 16 | $323 |
| Abbvie Inc. ABBV | 15 | $297 |
| Merck Sharp & Dohme LLC MRK | 12 | $249 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $161 |
| Genentech USA, Inc. ROG.SW | 7 | $158 |
| Genzyme Corporation SNY | 7 | $157 |
| Incyte Corporation INCY | 6 | $155 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.